| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Analysis of the breast cancer methylome using formalin-fixed paraffin-embedded tumour
|
Wong, Ee Ming
|
|
2016
|
160 |
1 |
p. 173-180
|
article
|
| 2 |
ANG1005 for breast cancer brain metastases: correlation between 18F-FLT–PET after first cycle and MRI in response assessment
|
O’Sullivan, C. C.
|
|
2016
|
160 |
1 |
p. 51-59
|
article
|
| 3 |
Clinical implications of routine genomic mutation sequencing in PIK3CA/AKT1 and KRAS/NRAS/BRAF in metastatic breast cancer
|
Cejalvo, Juan Miguel
|
|
2016
|
160 |
1 |
p. 69-77
|
article
|
| 4 |
Cost-effectiveness analysis of 1st through 3rd line sequential targeted therapy in HER2-positive metastatic breast cancer in the United States
|
Diaby, Vakaramoko
|
|
2016
|
160 |
1 |
p. 187-196
|
article
|
| 5 |
EMSY copy number variation in male breast cancers characterized for BRCA1 and BRCA2 mutations
|
Navazio, Anna Sara
|
|
2016
|
160 |
1 |
p. 181-186
|
article
|
| 6 |
Evaluation of the effect of compression therapy using surgical gloves on nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: a phase II multicenter study by the Kamigata Breast Cancer Study Group
|
Tsuyuki, Shigeru
|
|
2016
|
160 |
1 |
p. 61-67
|
article
|
| 7 |
Haplotype analyses of the c.1027C>T and c.2167_2168delAT recurrent truncating mutations in the breast cancer-predisposing gene PALB2
|
Catucci, Irene
|
|
2016
|
160 |
1 |
p. 121-129
|
article
|
| 8 |
Impact of androgen receptor expression in fluoxymesterone-treated estrogen receptor-positive metastatic breast cancer refractory to contemporary hormonal therapy
|
Kono, Miho
|
|
2016
|
160 |
1 |
p. 101-109
|
article
|
| 9 |
Inhibition of EGFR, HER2, and HER3 signaling with AZD8931 in combination with anastrozole as an anticancer approach: Phase II randomized study in women with endocrine-therapy-naïve advanced breast cancer
|
Johnston, Stephen
|
|
2016
|
160 |
1 |
p. 91-99
|
article
|
| 10 |
Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer
|
O’Neal, Julie
|
|
2016
|
160 |
1 |
p. 29-40
|
article
|
| 11 |
Initial experience of the BREAST-Q breast-conserving therapy module
|
O’Connell, Rachel L.
|
|
2016
|
160 |
1 |
p. 79-89
|
article
|
| 12 |
Long-term outcome in young women with breast cancer: a population-based study
|
Fredholm, Hanna
|
|
2016
|
160 |
1 |
p. 131-143
|
article
|
| 13 |
Patterns of multidisciplinary care in the management of non-metastatic invasive breast cancer in the United States Medicare patient
|
Churilla, Thomas M.
|
|
2016
|
160 |
1 |
p. 153-162
|
article
|
| 14 |
Ten-year survival in women with primary stage IV breast cancer
|
Eng, Lee Guek
|
|
2016
|
160 |
1 |
p. 145-152
|
article
|
| 15 |
The relationship between time to initiation of adjuvant chemotherapy and survival in breast cancer: a systematic review and meta-analysis
|
Raphael, Michael J.
|
|
2016
|
160 |
1 |
p. 17-28
|
article
|
| 16 |
To be young, Black, and living with breast cancer: a systematic review of health-related quality of life in young Black breast cancer survivors
|
Samuel, Cleo A.
|
|
2016
|
160 |
1 |
p. 1-15
|
article
|
| 17 |
Trends and variation in the use of nipple-sparing mastectomy for breast cancer in the United States
|
Sisco, Mark
|
|
2016
|
160 |
1 |
p. 111-120
|
article
|
| 18 |
Use of a multiplexed immunoassay (PRO Onc assay) to detect HER2 abnormalities in circulating tumor cells of women with HER2-negative metastatic breast cancer: lack of response to HER2-targeted therapy
|
Hainsworth, John D.
|
|
2016
|
160 |
1 |
p. 41-49
|
article
|
| 19 |
Young adult breast cancer patients have a poor prognosis independent of prognostic clinicopathological factors: a study from the Japanese Breast Cancer Registry
|
Kataoka, Akemi
|
|
2016
|
160 |
1 |
p. 163-172
|
article
|
Journal description